The path from research compound to approved medicine is long, costly, and uncertain
Because berberine already has glucose-lowering effects similar to some diabetes medications, combining it with GLP-1 drugs may amplify those effects
10.1016/j.repbio.2019.12.009 193 SklanE
BPC-157 is a 15-amino-acid peptide originally identified as a fragment of a gastric protective protein
Published Research Loren Pickarts 2008 review in the Journal of Biomaterials Science, Polymer Edition described how the GHK-Cu complex chemoattracts repair cells, suppresses several inflammatory markers, and increases synthesis of collagen, elastin, and related growth factors, while also reporting increases in hair follicle size in treated tissue models (Pickart, 2008, PMID 18644225)